|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5,527.00 JPY | +0.14% |
|
-0.32% | +1.82% |
Company Valuation: Kobayashi Pharmaceutical Co., Ltd.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 704,427 | 650,295 | 503,841 | 463,131 | 403,511 | 410,870 | - | - |
| Change | - | -7.68% | -22.52% | -8.08% | -12.87% | 1.82% | - | - |
| Enterprise Value (EV) 1 | 596,011 | 546,554 | 424,992 | 398,232 | 333,575 | 344,867 | 340,642 | 334,769 |
| Change | - | -8.3% | -22.24% | -6.3% | -16.24% | 3.39% | -1.23% | -1.72% |
| P/E | 35.8x | 34.8x | 25.3x | 46x | 110x | 39.2x | 30x | 24.4x |
| PBR | 3.59x | 3.47x | 2.47x | 2.18x | 1.92x | 1.94x | 1.9x | 1.84x |
| PEG | - | 12.08x | 7.7x | -0.9x | -1.7x | 0x | 1x | 1.1x |
| Capitalization / Revenue | 4.54x | 3.91x | 2.9x | 2.8x | 2.43x | 2.38x | 2.28x | 2.2x |
| EV / Revenue | 3.84x | 3.29x | 2.45x | 2.4x | 2.01x | 2x | 1.89x | 1.79x |
| EV / EBITDA | 19.3x | 17.1x | 13.3x | 12.1x | 14.1x | 15.3x | 12.9x | 11.1x |
| EV / EBIT | 22.9x | 20.5x | 16.5x | 16x | 22.4x | 25.7x | 19.3x | 15.5x |
| EV / FCF | 31.8x | 31.1x | -350x | -29.2x | 68.5x | 23.2x | 22.4x | 19.4x |
| FCF Yield | 3.15% | 3.22% | -0.29% | -3.42% | 1.46% | 4.3% | 4.46% | 5.14% |
| Dividend per Share 2 | 83 | 90 | 101 | 102 | 104 | 106 | 109.7 | 115 |
| Rate of return | 0.92% | 1% | 1.49% | 1.64% | 1.92% | 1.92% | 1.99% | 2.08% |
| EPS 2 | 252.4 | 259.6 | 268.2 | 135.4 | 49.19 | 140.8 | 184.1 | 226.5 |
| Distribution rate | 32.9% | 34.7% | 37.7% | 75.3% | 211% | 75.3% | 59.6% | 50.8% |
| Net sales 1 | 155,252 | 166,258 | 173,455 | 165,600 | 165,742 | 172,652 | 179,982 | 186,853 |
| EBITDA 1 | 30,900 | 32,027 | 31,837 | 32,800 | 23,600 | 22,516 | 26,475 | 30,230 |
| EBIT 1 | 26,065 | 26,669 | 25,780 | 24,860 | 14,923 | 13,440 | 17,657 | 21,601 |
| Net income 1 | 19,715 | 20,022 | 20,338 | 10,067 | 3,656 | 10,453 | 13,621 | 16,694 |
| Net Debt 1 | -108,416 | -103,741 | -78,849 | -64,899 | -69,936 | -66,004 | -70,229 | -76,101 |
| Reference price 2 | 9,040.00 | 9,030.00 | 6,790.00 | 6,230.00 | 5,428.00 | 5,527.00 | 5,527.00 | 5,527.00 |
| Nbr of stocks (in thousands) | 77,923 | 72,015 | 74,203 | 74,339 | 74,339 | 74,339 | - | - |
| Announcement Date | 2/4/22 | 2/14/23 | 2/9/24 | 2/10/25 | 2/10/26 | - | - | - |
1JPY in Million2JPY
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 39.25x | 2x | 15.32x | 1.92% | 2.53B | ||
| 22.09x | 4.29x | 15.71x | 2.84% | 349B | ||
| 18.12x | 2.74x | 12.13x | 3.45% | 135B | ||
| 26.19x | 3.78x | 15.89x | 2.29% | 74.4B | ||
| 44.61x | 7.15x | 31.05x | 2.11% | 52.31B | ||
| 19.92x | 2.81x | 11.64x | 4.47% | 36.44B | ||
| 79.78x | 2.36x | 14.24x | 1.71% | 29.71B | ||
| 16.32x | 1.57x | 8.9x | 3.24% | 19.89B | ||
| 18.42x | 1.34x | 7.99x | 1.28% | 19.85B | ||
| 21.91x | 1.58x | 10.09x | 2.36% | 18.43B | ||
| Average | 30.66x | 2.96x | 14.30x | 2.57% | 73.82B | |
| Weighted average by Cap. | 25.39x | 3.78x | 15.37x | 2.84% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- 4967 Stock
- Valuation Kobayashi Pharmaceutical Co., Ltd.
Select your edition
All financial news and data tailored to specific country editions
















